As COVID-19 — and cold, flu and RSV — season dawns, vaccination rates are continuing to lag across Wisconsin, data show. As of Oct. 9, just 2.5% of Wisconsin residents had received at least one dose ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

An international research team has determined the first high-resolution structures of the herpes simplex virus origin-binding protein (OBP), a critical component of viral DNA replication that has ...

The discovery could serve as a starting point for antiviral strategies. A research team at Ruhr University Bochum, Germany, ...

Researchers at Google Quantum AI have used their Willow quantum computer to help interpret data from Nuclear Magnetic Resonance (NMR) spectroscopy, a mainstay of chemistry and biology research. The ...

DEAR DR. FOX: Your column entitled “Safety, Effectiveness of COVID-19 Vaccinations” was well balanced, but it gave too much weight to the Joseph Fraiman et al. article published in Vaccine in 2022.

– FDA approval based on superiority of Gazyva over standard therapy alone, as shown in Phase II NOBILITY and Phase III REGENCY data – – Gazyva is the only anti-CD20 monoclonal antibody to demonstrate ...

Novel Coronavirus (COVID-19) The COVID-19 pandemic caused by the novel coronavirus (SARS-CoV-2) continues to reshape the globe. Stay current with the latest updates essential for healthcare ...